Combination Compositions Composed ofl-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model
Open Access
- 17 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 918
- https://doi.org/10.3389/fphar.2020.00918
Abstract
Intestinal mucositis is a common toxicity of many anti-neoplastic therapies that negatively influences health, the quality of life, economic outcomes, and even the success of cancer treatment. Unfortunately, there is presently no optimal medicine that is able to effectively manage this condition.l-glutamine is one of the most frequently used agent in practice among the limited treatment choices due to its safety and inexpensiveness despite there being a lack of evidence. Previous studies indicated thatl-glutamine may alleviate mucositis and mucosal atrophy but failed to improve patients' macroscopic conditions, such as the occurrence of diarrhea. A compound glutamine capsule (G-SJZ), composed ofl-glutamine and the traditional Chinese herbal formula Si-Jun-Zi-Tang, has been used in China for 23 years to treat many types of gastrointestinal diseases, including gastrointestinal reactions induced by radiotherapy and chemotherapy. However, the exact effect of G-SJZ on intestinal mucositis is unclear, and moreover, whetherl-glutamine combined with Si-Jun-Zi-Tang is more effective thanl-glutamine alone have not been studied. In the current study, we explored the effects of G-SJZ andl-glutamine in a mouse model of intestinal mucositis induced by 5-fluorouracil (5-Fu). The results revealed that pretreatment with G-SJZ ameliorated the physical manifestations of weight loss and the severity of diarrhea following continuous 5-Fu injections in mice. Likewise, the histopathological damage and the destruction of villus and crypt structures in the intestinal mucosa as well as the increase in circulating intestinal injury markers caused by 5-Fu were reversed with G-SJZ pretreatment. Furthermore, the protective effect of G-SJZ was accompanied by modulations in the immunohistochemical expression of tight junction proteins. Interestingly, although treatment with a dose ofl-glutamine alone that was equivalent to the dose in G-SJZ also showed a protective effect, it did not appear to be as strong as treatment with G-SJZ. Si-Jun-Zi-Tang in G-SJZ may compensate for the deficiencies ofl-glutamine in this model which seems not to be related to the regulation of tight junction proteins. Our study is the first to suggest that the combined use ofl-glutamine and Si-Jun-Zi-Tang might be more effective thanl-glutamine alone despite exact mechanism still needs further study. Because of the limited number of therapeutic agents, G-SJZ is likely to be a preferable choice for intestinal mucositis.Keywords
This publication has 36 references indexed in Scilit:
- Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cellsClinical Nutrition, 2013
- Systematic review of agents for the management of gastrointestinal mucositis in cancer patientsSupportive Care in Cancer, 2012
- Nutritional Modulation of Antitumor Efficacy and Diarrhea Toxicity Related to Irinotecan Chemotherapy in Rats Bearing the Ward Colon TumorClinical Cancer Research, 2007
- Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerationsNature Clinical Practice Gastroenterology & Hepatology, 2007
- Glutamine: Do the Data Support the Cause for Glutamine Supplementation in Humans?Gastroenterology, 2006
- TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil–induced mucositis in miceNutrition, 2004
- Clinical evidence for enteral nutritional support with glutamine:Nutrition, 2003
- Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trialGut, 2001
- Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancerEuropean Journal Of Cancer, 1999